Medico Remedies Limited (MEDICO.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹20.48 (+1.99%) as of
Key statistics
- Market cap
- 1.70B
- P/E (TTM)
- 12.34
- EPS (TTM)
- 1.66
- Dividend yield
- 0.00%
- 52-week range
- 19.11 – 56.88
- Beta
- 0.71
- Revenue (TTM)
- 2.38B
- Profit margin
- 5.82%
- Volume
- 25.26k
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as antihypertensive, antidiabetics, antibiotics diuretics, and antiretrovirals. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Mumbai, India
- Employees
- 105
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.